Related Experiment Video
Updated: Aug 21, 2026

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
Anti-inflammatory approaches in cancer immunotherapy-induced autoimmunity
1Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
None:
Cancer immunotherapy, including allogeneic haematopoietic cell transplantation, infusion of chimeric antigen receptor T (CAR-T) cells, bispecific antibodies, and immune checkpoint inhibitors (ICIs), has revolutionised the treatment of cancer. However, therapy resistance and immune-mediated side effects reduce the overall success. Recent developments in these 2 areas were reported at the 2026 ATT conference. Treatment of immune effector cell-associated neurotoxicity syndrome (ICANS) using transforming growth factor β (TGFβ)-activated kinase-1 (TAK1)-NF-κB-p38 mitogen-activated protein kinase (MAPK) pathway inhibition was shown to be effective in preclinical models. TAK1 inhibition reduced microglia activation and improved neurocognitive function after CAR19 T-cell transfer. This review discusses new developments in the fields of ICANS, graft-vs-host disease (GVHD), and ICI-mediated side effects.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cross-reactivity
Inflammatory Bowel Disease III: Crohn's Disease

